Abstract
Introduction
The supply of essential fatty acids and long-chain polyunsaturated fatty acids (LCP) is important for normal growth and development of infants. Their contents in human milk depend on maternal nutrition, utilization, and composition of depot fats and endogenous LCP synthesis from precursors [1] [2] [3] . Essential fatty acids and LCP may also be used as an energy source and thus be oxidized to CO 2 . Methods for measuring the in vivo oxidation of substrates labeled with the nonradioactive isotope 13 C have been increasingly used for diagnostic and research purposes [4] [5] [6] . Small excesses of exogenous 13 CO 2 arising from oxidation of the labeled substrate can be measured by sensitive mass spectrometry techniques [5, 6] .
The first objective of this study was to investigate the oxidation of an orally applied 13 C-labeled oil rich in docosahexaenoic acid (DHA; DHASCO ® , Martek Biosciences, Columbia, Md., USA) in a group of lactating mothers supplemented either with DHA or a placebo oil. The second objective was to compare the oxidation of this fatty acid mixture containing about 40% DHA with the oxidation of a single polyunsaturated fatty acid (linoleic acid) in lactation.
Subjects and Methods
Ten healthy breast-feeding mothers were recruited after term delivery at the Department of Gynecology and Obstetrics, University of Munich. The study was approved by the Ethical Committee of the Medical Faculty of the University of Munich, and written consent was obtained from the participating women.
The women were 31 B (SD) 5 years old and had a weight of 71.4 B 4.6 kg (at 4 weeks post partum) and a height of 170 B 6 cm. All were consuming omnivorous diets which were assessed by 7-day weighted dietary protocols. At 4 weeks post partum (study day 0), they were randomly and blindly assigned to receive either a Compositional data provided by the manufacturer.
dietary supplement rich in DHA (200 mg DHA/day from DHASCO capsules) or a placebo oil for 14 days. The mothers were asked not to eat fish (rich in n-3 LCP) during the 2-week supplementation period. Further, they were asked not to eat corn-based products the day before tracer application because of an elevated 13 C content. At 6 weeks post partum mothers from both groups received with their breakfast a single dose of 2 mg/kg of uniformly 13 C-labeled DHASCO oil (57.1-65.7% 13 C enrichment). The fatty acid compositions of the DHASCO and placebo capsules as well as the tracer are shown in table 1. In a previously published comparable study [1] , 6 breast-feeding mothers (age 31 B 3 years, weight 68.17 B 8.2 kg, height 167 B 3 cm; mean B SD) received a single dose of uniformly 13 C-labeled linoleic acid (F98% 13 C labeling; Martek Biosciences) at 6 weeks post partum.
Exhaled breath samples were collected into 1-liter breath bags. An aliquot of 11 ml was transferred into evacuated glass tubes (Labco, Manchester, UK) and stored until measurement of the 13 C content of the CO 2 . Immediately before tracer application a breath sample was taken in triplicate in order to measure baseline 13 C enrichment of CO 2 . Further samples were collected 30 min and 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 24, 36, and 48 h after tracer administration. The total CO 2 production was measured by indirect calorimetry twice in each woman from 30 min preprandial until 30 min postprandial (Deltatrac ® II MBM-200; Hoyer, Bremen, Germany). The 13 C enrichments of breath CO 2 were measured in duplicate by isotopic ratio mass spectrometry (Delta S; Finnigan MAT, Bremen). Carbon isotope ratios were expressed as ‰ 13 C values (‰) versus the Pee Dee Belemnite standard. The oxidation rates over 48 h were calculated as described elsewhere [1] .
Statistical differences between the DHA-supplemented group and the placebo group as well as between the groups combined (supplemented and placebo groups; n = 10) and the group given 13 C linoleic acid were assessed by a nonparametric test (Mann-Whitney, Monte Carlo) using the Stastical Package for the Social Sciences (version 8.0; SPSS, Chicago, Ill., USA). This test was chosen due to the relatively small number of subjects per group. The significance level was set at p ! 0.05, and the results are presented as median and interquartile range (IQR).
Results
The times of peak 13 C enrichment in breath CO 2 (delta over baseline, DOB) of the DHA-supplemented group and the placebo group were at 1 h (1.0-1.0; median and IQR) and at 2 h (1.0-3.3), respectively (table 2) . Forty-eight hours after tracer application 13 C enrichment in both groups had almost returned to baseline values [DOB 0.21‰ (0.04-0.59)]. Because of the nearly identical kinetics of the supplemented and the placebo group, both were combined for comparison with the linoleic acid group.
Time of peak 13 C enrichment in the combined group was at 1 h (1.0-2.0) after tracer application which was about 3 h earlier than in the linoleic acid group [3.5 h (3.0-4.0); p = 0.003].
The percentage of the dose of tracer 13 C exhaled in CO 2 per hour (percent dose recovery; PDR/h) tended to be slightly higher during the first 2 h after tracer application in the DHA-supplemented versus the placebo group which was not significantly different due to large interindividual differences ( fig. 1) . From 3 to 48 h after tracer application, the tracer oxidation did not differ between the supplemented and the placebo groups.
A comparison of the combined group and the linoleic acid group showed a severalfold higher PDR/h in the group receiving labeled DHASCO during the first 4 h after tracer application: 18-fold higher at 1 h after tracer ingestion, 7-fold higher at 2 h, 3.4-fold higher at 3 h, and 1.6-fold higher at 4 h ( fig. 2) . At the later time points, 5-24 h after tracer application, there were no significant differences between the combined and the linoleic acid group. At 30 and 48 h after tracer application, the PDR/h in the linoleic acid group versus the combined group was higher The cumulative PDR/h of tracer doses in breath tended to be higher in the DHA-supplemented group than in the placebo group during the first 2 h after tracer application. This difference was significant only at 1 h after the tracer application [1.61% (1.38-1.77) in the supplemented vs. 0.76% (0.40-1.15) in the placebo group, p = 0.033].
The cumulative recovery of 13 C in the combined group at 1 h after tracer ingestion was 10.7-fold higher than in the linoleic acid group (1.28 vs. 0.12). This tendency was observed during the first 10 h after tracer application. From 24 to 48 h after tracer application, the cumulative recovery of DHASCO and linoleic acid was very similar and reached about 15% of the ingested doses ( fig. 3 ). 
Discussion
In this study, we investigated the oxidation of an oil rich in DHA and compared these results with data obtained in a previous study on linoleic acid oxidation in lactating women.
DHASCO is a refined single-cell triglyceride oil highly enriched in DHA that is produced by the microalgal strain MK 8805 [7] . Due to positional preference of DHA for sn-1 and sn-3, it is more similar to mammal than to fish oil. It is used as a dietary supplement to elevate the levels of DHA in conventional foods, especially in infant formulas [7, 8] . DHASCO labeled with 13 C, a safe nonradioactive isotope that causes no radiation risk to mother or infant [4, 9, 10] , was used to measure fatty acid oxidation. Breath tests using stable isotopic labeled substrates are generally considered as safe and noninvasive tests to measure in vivo substrate oxidation [6, [11] [12] [13] .
The baseline 13 C content in breath CO 2 of mothers from the combined group was 1.0838 atom percent (1.0837-1.0839; median and IQR) and achieved peak 13 C enrichment of 1.1051 atom percent (1.1027-1.1082) which represents !2% enrichment over the baseline. The baseline 13 C content in breath CO 2 measured in our study is slightly lower than the natural average 13 C abundance reported in Europeans (1.088) [14] . This is a reflection of the local Bavarian diet, with little intake of maize and cane sugar, but high in proportions of potato, cabbage, rice, and beet sugar, as well as the overnight fasting.
Our results show no apparent difference in the kinetics and the cumulative oxidation rate between the groups of women that were supplemented or not supplemented with DHASCO over a period of 14 days. The direct measurement of DHA oxidation was not intended in this study. This would have only been possible using a pure DHA tracer, instead of a mixture of different fatty acids.
We combined the results of the DHA-supplemented and the placebo groups and compared the oxidation of a single oral dose of 13 C-DHASCO with the results of the 13 C-linoleic acid oxidation obtained in a previous study [1] . Time points of sampling exhaled air and the measurement of 13 C enrichment of breath CO 2 were performed in the same way and using the same instruments as in the current study.
Earlier maximum 13 C enrichment in breath CO 2 (DOB) in the combined group versus the linoleic acid group (1.0 vs. 3.5; median) reflects the faster oxidation rate of the DHASCO tracer. Different kinetics of the oxidation of the two tracers can also be seen from the data of the PDR/h ( fig. 1 ) and the cumulative recovery of the tracer in breath ( fig. 3) .
The oxidation rate of DHASCO tracer versus linoleic acid was faster, especially during the first 4 h after its ingestion. The 13 C-labeled DHASCO tracer is a triglyceride-oil mixture that contains twelve different fatty acids, with the main components being lauric (C12:0), myristic (C14:0), and palmitic acid (C16:0) and DHA (C22:6n-3) which represent 84.2-97.5 w% of all the fatty acids (table 1) . From the oxidation data alone, it is difficult to speculate which fatty acids are the ones with faster oxidation in DHASCO as compared with linoleic acid. Cumulative 13 C enrichments of single fatty acids at 48 h in human milk of mothers from the combined DHASCO group were severalfold higher for C16:0, C16:1n-7, C18:1n-9, and C22:6n-3 than for of C14:0 [unpubl. data]. This could be explained by a greater rate of C14:0 oxidation in comparison with other mono-and polyunsaturated fatty acids contained in DHASCO. This preservation from oxidation is in agreement with the results of a study performed by Metges and Wolfram [15] who found greater and more rapid oxidation of trioctanoate as compared with trioleate after oral and parenteral administration in healthy adult volunteers.
It is likely that the faster oxidation rate of DHASCO, as compared to linoleic acid, is due to a quicker absorption and oxidation of shorter-chain saturated fatty acids (C8:0, C10:0, C12:0, and C14:0) contained in DHASCO. The cumulative oxidation of DHASCO is about 15% of the dose at 48 h after ingestion. This value is comparable to values obtained in other studies measuring fatty acid oxidation. Although there were differences in the kinetics of oxidation between the DHASCO group and the linoleic acid group, the cumulative oxidation 1 and 2 days after tracer application did not differ.
